证券代码：833580 证券简称：科创新材 公告编号：2025-043 洛阳科创新材料股份有限公司 关于开立募集资金现金管理专用结算账户的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 洛阳科创新材股份有限公司（以下简称"公司"）于 2024 年 8 月 14 日召 开了第四届董事会第二次会议、第四届监事会第二次会议，审议通过了《关于公 司使用部分闲置募集资金购买理财产品的议案》，同意公司在确保资金安全、不 影响募集资金投资项目建设的前提下，拟使用额度不超过人民币 3,000.00 万元 的闲置募集资金购买理财产品，拟投资的品种为安全性高、 流动性好、优选本 金安全的理财产品、协定存款、定期存款、通知存款或结构性存款等产品。在前 述额度内，资金可以循环滚动使用，拟投资的期限最长不超过 12 个月，不影响 募集资金投资计划正常进行。决议自公司董事会审议通过之日起 12 个月内有效， 如单笔产品存续期超过前述有效期，则决议的有效期自动顺延至该笔交易终止之 日止。公司保荐机构川财证券有限责任公司出具了无 ...

Core Insights - The article highlights the significance of the new materials sector in China's technology-driven economy, emphasizing its rapid growth and potential investment opportunities as the Sci-Tech Innovation Board celebrates its sixth anniversary [1][15]. Group 1: New Materials Overview - New materials are defined as advanced materials developed over the past 50 years, characterized by superior performance, higher technological content, and broader applications compared to traditional materials [2]. - The new materials industry in China is projected to reach a value of 10 trillion yuan by 2025, with an average annual growth rate of approximately 15% from 2016 to 2023 [2]. - The demand for new materials is rapidly increasing, driven by technological advancements and policy support, indicating a potential acceleration in the industry’s growth phase [3]. Group 2: Demand Drivers - The semiconductor sector is experiencing a recovery, with strong demand for semiconductor materials due to the decline in global inventory and the ongoing AI trend, which is increasing storage capacity needs [3]. - The pharmaceutical sector is witnessing growth in innovative drugs and synthetic biological materials, supported by favorable policies and an expanding payment system [5]. - The military sector is seeing increased demand, highlighted by China's significant military exports, which account for 5.9% of the global arms trade market [8]. - The renewable energy sector, particularly solar and electric vehicles, is expected to improve supply-side conditions, indicating a potential turnaround in demand [9]. Group 3: Investment Opportunities in New Materials - New materials can be categorized into high-growth tracks, performance realization tracks, and early-stage blue ocean tracks, with a focus on AI and electronic materials in the high-growth category [12]. - The high-growth track is expected to see revenue and net profit growth rates of +1.4% and +29.6% respectively in 2024, with significant improvements in advanced packaging materials and synthetic biology [12]. - The performance realization track indicates a shift towards domestic alternatives in semiconductor quartz glass materials and a recovery in nylon demand, suggesting potential revenue and profit increases [12]. Group 4: ETF Launch and Market Positioning - The newly launched Sci-Tech Innovation Materials ETF (589180) aims to provide a low-threshold, high-efficiency investment opportunity in the new materials sector, tracking a representative index of 50 major companies in advanced materials [15][26]. - The ETF's index is well-balanced, focusing on leading companies in sectors such as new energy materials, semiconductor materials, and aerospace materials, with a significant portion of its assets allocated to top-performing firms [17]. - The ETF is positioned at a low valuation level, with a strong rebound since its recent low, indicating a favorable risk-reward profile for investors [21].

实用新型名称：一种滑板砖外形尺寸检测卡尺 专利号：ZL 2024 2 1994096.3 证券代码：833580 证券简称：科创新材 公告编号：2025-042 洛阳科创新材料股份有限公司 关于取得实用新型专利证书的公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 洛阳科创新材料股份有限公司（以下简称："公司"）近日收到中华人民共和 国国家知识产权局颁发的一项实用新型专利证书。具体情况如下： 该实用新型专利的取得有利于提升公司的核心竞争力，保护公司知识产 权，有利于公司形成持续的创新机制。 二、备查文件 （一）实用新型专利证书（证书号 第 22922740 号） 洛阳科创新材料股份有限公司 董事会 2025 年 6 月 3 日 专利申请日：2024 年 08 月 16 日 专利权人：洛阳科创新材料股份有限公司 授权公告日：2025 年 06 月 03 日 一、 对公司的影响 ...

本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 洛阳科创新材料股份有限公司 2024 年年度权益分派方案已获 2025 年 5 月 15 日召开的股东会审议通过，本次实施分配方案距离股东会审议通过的时间未 超过两个月。 现将权益分派事宜公告如下： 本次权益分派基准日合并报表归属于母公司的未分配利润为 111,867,298.59 元，母公司未分配利润为 111,867,385.19 元。本次权益分派共计派发现金红利 6,020,000.00 元。 证券代码：833580 证券简称：科创新材 公告编号：2025-041 洛阳科创新材料股份有限公司 2024 年年度权益分派实施公告 二、权益登记日与除权除息日 本次权益分派权益登记日为：2025 年 5 月 26 日 除权除息日为：2025 年 5 月 27 日 一、权益分派方案 1、本公司 2024 年年度权益分派方案为： 以公司现有总股本 86,000,000 股为基数，向全体股东每 10 股派 0.700000 元人民币现金。 2、扣税说明 （1）个人 ...

证券代码：833580 证券简称：科创新材 公告编号：2025-039 洛阳科创新材料股份有限公司 （一）会议召开情况 1.会议召开时间：2025 年 5 月 15 日 2.会议召开地点：公司会议室 3.会议召开方式：现场会议和网络投票相结合 4.会议召集人：董事会 2024 年年度股东会决议公告 本公司及董事会全体成员保证公告内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连 带法律责任。 一、会议召开和出席情况 5.会议主持人：董事长蔚文绪先生 6.召开情况合法合规的说明： 会议召集、召开、议案审议程序等方面符合有关法律、行政法规、部门规章、 规范性文件和《公司章程》的规定。 （二）会议出席情况 出席本次股东会的股东共 7 人，持有表决权的股份总数 54,158,734 股，占 公司有表决权股份总数的 62.9753%。 其中通过网络投票参与本次股东会的股东共 2 人，持有表决权的股份总数 10,779,606 股，占公司有表决权股份总数的 12.5344%。 （三）公司董事、监事、高级管理人员出席或列席股东会情况 1.公司在任董事 7 人，出席 ...

() 朕营律师事务所 KAYUI LAW FIRM 金鹏家裔(横琴) 联营律师事务所 关于洛阳科创新材料股份有限公司 2024 年年度股东会 法律意见书 二零二五年五月 地址:广东省珠海市横琴粤澳深度合作区汇通三路108号中大金融中心1号楼2610-2617室 Address: Room 2610-2617, Building 1, Zhongda Financial Center, No.108 Huitong 3rd Road, Guangdong-Macao In-Depth Cooperation Zone in Hengqin, Guangdong Province 邮编 (Postal Code) : 519000 电话(Tel): (+86) 0756-8899220 法律意见书 金鹏家裔 (横琴) 联营律师事务所 关于洛阳科创新材料股份有限公司 2024年年度股东会 法律意见书 金鹏家裔(2025) 法意字第 003 号 致: 洛阳科创新材料股份有限公司 3. 本法律意见书仅为本次股东会之目的而使用,不得用于其他任何目的或用途。 本所同意公司将本法律意见书作为本次股东会文件予以公告。 基于上述 ...

本公司及董事会全体成员及相关股东保证公告内容不存在虚假记载、误导性 陈述或重大遗漏，并对其内容的真实、准确和完整承担个别及连带责任。 一、 减持主体减持前基本情况 | 股东名称 | 股东身份 | 持股数量 | 持股比例 | 当前持股股份来源 | | --- | --- | --- | --- | --- | | | | （股） | （%） | | | 徐韦楠 | 持股 5%以上 | 7,214,523 | 8.3890% | 北交所上市后取得 | | | 股东 | | | | 证券代码：833580 证券简称：科创新材 公告编号：2025-038 洛阳科创新材料股份有限公司 持股 5%以上股东减持股份结果公告 √减持计划实施完毕 □减持时间区间届满 洛阳科创新材料股份有限公司 董事会 2025 年 5 月 15 日 （一） 股东因以下原因披露减持计划实施结果： | | | 减持数 | | | | | 减 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | 量占总 | | | | | 持 | | | | 股 | | ...

| 股东名称 | 股东身份 | 持股数量 | 持股比例 | 当前持股股份来源 | | --- | --- | --- | --- | --- | | | | （股） | （%） | | | 程鹏 | 持股 5%以上 | 4,880,025 | 5.6744% | 北交所上市后取得 | | | 股东 | | | | 证券代码：833580 证券简称：科创新材 公告编号：2025-036 洛阳科创新材料股份有限公司 持股 5%以上股东减持股份结果公告 本公司及董事会全体成员及相关股东保证公告内容不存在虚假记载、误导性 陈述或重大遗漏，并对其内容的真实、准确和完整承担个别及连带责任。 一、 减持主体减持前基本情况 三、 备查文件 （一）程鹏出具的《程鹏股份减持结果情况告知函》 洛阳科创新材料股份有限公司 董事会 二、 减持计划的实施结果 （一） 股东因以下原因披露减持计划实施结果： √减持计划实施完毕 □减持时间区间届满 | | | 减持数 | | | | | | 减 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ...

Group 1: Investor Relations Activity Overview - The company held an earnings briefing on April 29, 2025, from 15:00 to 17:00 [3] - The event was conducted via the "Investor Relations Interactive Platform" [3] - Key attendees included the Chairman, Secretary of the Board, and financial responsible personnel [3] Group 2: Key Issues Addressed - Concerns were raised regarding the executive compensation being relatively low compared to the overall level in the Beijing Stock Exchange [5] - The company explained that executive compensation is determined based on various factors including regional economic development, industry standards, and job responsibilities [5] - The company emphasized that the current compensation structure does not negatively impact the stability and motivation of the executive team [5] - Future plans include continuous improvement of the compensation system and increasing executive remuneration based on investor feedback [5]

Financial Performance - Net profit attributable to shareholders for Q1 2025 was CNY 2,248,217.51, down 48.89% year-over-year[9] - Operating revenue for Q1 2025 was CNY 17,022,544.84, representing an 8.16% decline compared to the same period last year[9] - The company experienced a 44.85% decline in operating profit, amounting to CNY 3,207,593.77, influenced by rising raw material costs and weak market demand[12] - Total operating revenue for Q1 2025 was ¥17,022,544.84, a decrease from ¥18,534,621.71 in Q1 2024, representing a decline of approximately 8.14%[36] - Net profit for Q1 2025 was ¥2,248,217.51, down from ¥4,398,778.98 in Q1 2024, indicating a decrease of approximately 48.91%[37] - Basic earnings per share decreased to CNY 0.03 from CNY 0.05 year-over-year[39] Assets and Liabilities - Total assets as of March 31, 2025, were CNY 358,898,039.96, a decrease of 0.80% compared to the end of the previous year[9] - The company reported a total asset value of ¥358,898,039.96, down from ¥361,778,172.84[30] - Total liabilities decreased to ¥26,562,094.93 from ¥31,690,445.32, a reduction of about 16.3%[31] - Total liabilities decreased to ¥26,562,094.93 in Q1 2025 from ¥31,690,445.32 in the previous year, a reduction of approximately 16.4%[35] - Shareholders' equity increased to ¥332,335,945.03 from ¥330,087,727.52, showing a growth of approximately 0.7%[31] - Owner's equity increased slightly to ¥332,336,360.42 in Q1 2025 from ¥330,087,814.12 in Q1 2024, showing a growth of about 0.68%[35] Cash Flow - The company's cash flow from operating activities showed a net outflow of CNY 7,876,472.18, worsening by 6.82% compared to the previous year[9] - Cash inflow from operating activities was CNY 15,242,896.92, up from CNY 13,372,342.09 in the same period last year, representing an increase of approximately 13.94%[40] - Cash outflow from operating activities totaled CNY 23,119,369.10, compared to CNY 20,745,817.05 in the previous year, reflecting an increase of about 11.46%[41] - Net cash flow from operating activities was negative at CNY -7,876,472.18, worsening from CNY -7,373,474.96 year-over-year[41] - Cash inflow from investment activities was CNY 30,148,651.47, primarily from cash recovered from investments[41] - Cash outflow from investment activities was CNY 3,591,820.32, down from CNY 32,977,896.90 in the previous year, indicating a significant reduction[41] - Net cash flow from financing activities was CNY 24,476,035.95, primarily due to cash received from borrowings of CNY 25,095,145.39[41] - The ending cash and cash equivalents balance decreased to CNY 56,066,652.21 from CNY 59,918,776.84 year-over-year[41] - The company reported a net increase in cash and cash equivalents of CNY -11,468,292.50 for the current period[41] Expenses - Research and development expenses increased by 38.60% year-over-year, totaling CNY 1,293,708.77, to enhance product competitiveness and develop new products[11] - Management expenses rose by 74.29% year-over-year, totaling CNY 2,562,638.39, primarily due to increased depreciation and consulting fees[12] - Total operating costs increased to ¥17,089,678.17 in Q1 2025 from ¥16,129,330.44 in Q1 2024, marking an increase of about 5.95%[36] - Financial expenses showed a net income of -¥276,541.00 in Q1 2025, compared to -¥126,349.27 in Q1 2024, indicating a worsening of financial costs[36] - Investment income recorded a loss of ¥241,932.12 in Q1 2025, contrasting with a gain of ¥62,984.01 in Q1 2024[36] Shareholder Information - Major shareholders include Wei Wenxu with 22.32% and Ma Junqiang with 16.76% of shares[18] - The total number of shares held by the top ten shareholders is 55,661,650, representing 64.72% of total shares[19] - There are no pledged or judicially frozen shares among the top ten shareholders[20] Legal and Compliance - The company is involved in litigation with a total claim amount of 1,110,862.09, which accounts for 0.33% of the net assets[23] - The company has pledged receivables worth 7,685,684.59, representing 2.14% of total assets[24] - The total value of assets with restricted rights is 8,641,816.90, accounting for 5.86% of total assets[24] - The company has no adverse effects from the pledged assets as they are part of normal business operations[25] - The financial report has not been audited[27] - The consolidated balance sheet is presented in yuan[28]